Facebook Linkedin Twitter
Inside Precision Medicine Proxygen Nets Deal Worth Up to $2.55B with Merck around Glue Degraders

Financial support

Ubiquitin activating enzyme protein E1
News & Features

Proxygen Nets Deal Worth Up to $2.55B with Merck around Glue Degraders

0
cancer
News & Features

Chen, Humphrey Lead Launch of New I-O Company Normunity with $65M Series A Financing

0
Close-up of male eye with round HUD display
News & Features

Eye Scan Medtech Raises $25 Million To Advance Neurology Diagnostics Tech

0
Lab workers in protective suits in a lab at the Kansas Center of BioModular Multi-Scale Systems for Precision Medicine making lab-on-a-chip devices.
Molecular Dx

NIH Grants Center Developing Precision Medicine Devices $6.6M in New Funding

0
Close up photo of a woman's eye to symbolize inherited eye diseases such as Bothnia dystrophy
News & Features

AbbVie Partners with Regenxbio to Develop anti-VEGF Eye Gene Therapy

0
Doctor preparing a vaccine for an injection
Coronavirus

AstraZeneca’s COVID-19 Vaccine Candidate Enters 30,000-Person Phase III Trial

0
Coronavirus Covid-19 Vaccine
Coronavirus

Novavax Secures $1.6B in Funding for COVID-19 Vaccine Efforts

0
An illustration of the human gut microbiome, which is altered in many Parkinson's disease patients
Molecular Dx

UC Irvine Pair Launch the Microbiome Centers Consortium

0
newborn baby
Molecular Dx

Invitae to Expand NIPS Services with Singular Bio Acquisition

0
MGI-genetic-sequencer
Molecular Dx

BGI Subsidiary Raises Over $200M in Initial Financing Round

0
123Page 2 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine